<DOC>
	<DOCNO>NCT00645021</DOCNO>
	<brief_summary>CP-945,598 eliminate follow extensive metabolism . Decrease hepatic function affect elimination body via metabolism . This study therefore compare pharmacokinetics ( time course drug concentration body ) , safety , tolerability CP-945,598 patient mild moderate hepatic impairment healthy control subject .</brief_summary>
	<brief_title>Study Examining The Effect Of Hepatic Impairment On Safety , Toleration And How The Body Processes An Experimental Drug</brief_title>
	<detailed_description />
	<mesh_term>Hepatic Insufficiency</mesh_term>
	<criteria>Healthy : Matched age ( ± 5 year ) , weight ( ± 10 kg ) , gender ( ±2 subject per gender ) Subjects hepatic disease : 1. mild impairment ( childpugh score 56 ) , moderate ( childpugh score 79 ) . 2. stable hepatic disease : change last 30 day . 3. stable dose medication and/or treatment . All subject : Nonprescribed use drug abuse/recreational drug ; recent treatment experimental drug herbal experiment ; ECG blood pressure fall outside protocolspecified limit ; history regular tobacco use exceed protocolspecified limit Normal subject : medically important health condition ; recent use prescription nonprescription medication ; history regular alcohol use exceed protocolspecified limit Subjects hepatic disease : childpuge score great 9 ; hepatic carcinoma hepatorenal syndrome ; Undergone portacaval shunt surgery ; History GI hemorrhage due esophageal varix peptic ulcer less 1 month prior study entry ; significant hepatic encephalopathy ; severe ascites and/or pleural effusion ; Positive blood alcohol test/alcohol breathalyzer screen Day 0 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2008</verification_date>
</DOC>